ACR Meeting Abstracts

ACR Meeting Abstracts

  • Home
  • Meetings Archive
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018 ACR/ARHP Annual Meeting
    • 2017 ACR/ARHP Annual Meeting
    • 2017 ACR/ARHP PRSYM
    • 2016-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • Meeting Resource Center

Abstracts tagged "Employment and Work Disability"

  • Abstract Number: 3056 • 2016 ACR/ARHP Annual Meeting

    Efficacy of a Work Disability Prevention Program for People with Rheumatic and Musculoskeletal Conditions: A Randomized Controlled Trial

    Julie J. Keysor1,2, Michael P. LaValley3, Carrie Brown4, David T. Felson5, Rawan AlHeresh6, Molly Vaughan7, Robert A. Yood8, John Reed9 and Saralynn Allaire10, 1Physical Therapy, Boston University, Boston, MA, 2Clinical Epidemiology Research and Training, Boston University School of Medicine, Boston, MA, 3Biostatistics, Boston University School of Public Health, Boston, MA, 4Boston University School of Public Health, Boston, MA, 5Clinical Epidemiology Unit, Boston University School of Medicine, Boston, MA, 6Rheumatology, King Faisal Specialist Hospital & Research Center, Riyadh, Saudi Arabia, 7635 Commonwealth Avenue, Room 651, Boston University College of Health & Rehabilitation Sciences, Boston, MA, 8Fallon Clinic, Worcester, MA, 9Rheumatology, Reliant Medical Group, Worcester, MA, 10Clinical Epidemiology Research and Training Unit, Clinical Epidemiology, BUSM, Boston, MA

    Background/Purpose: Rheumatic and musculoskeletal conditions are leading causes of work disability. A previous trial showed a preventive work disability intervention delivered by vocational rehabilitation counselors…
  • Abstract Number: 449 • 2013 ACR/ARHP Annual Meeting

    Work Instability In Early Rheumatoid Arthritis With Elevated Risk Of Employment Loss: Effects Of Adalimumab/Methotrexate Combination Therapy Versus Methotrexate In a Randomized Clinical Trial

    Arthur Kavanaugh1, Josef S. Smolen2, Arijit Ganguli3, Hartmut Kupper3, Mary Cifaldi3, Naijun Chen3 and Dennis Revicki4, 1University of California, San Diego, La Jolla, CA, 2Medical University of Vienna, Vienna, Austria, 3AbbVie Inc., North Chicago, IL, 4United BioSource, Bethesda, MD

    Background/Purpose: Intensive treatment of early rheumatoid arthritis (RA) has been shown to reduce functional disability over time and to positively impact employment outcomes. Adalimumab (ADA)…
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

ACR Pediatric Rheumatology Symposium 2020

© COPYRIGHT 2022 AMERICAN COLLEGE OF RHEUMATOLOGY

Wiley

  • Home
  • Meetings Archive
  • Advanced Search
  • Meeting Resource Center
  • Online Journal
  • Privacy Policy
  • Permissions Policies